Charting the Clinical Landscape of Lenvatinib-Integrated Therapies for Hepatocellular Carcinoma
- PMID: 40622563
- DOI: 10.1245/s10434-025-17778-9
Charting the Clinical Landscape of Lenvatinib-Integrated Therapies for Hepatocellular Carcinoma
Erratum in
-
Correction: Charting the Clinical Landscape of Lenvatinib-Integrated Therapies for Hepatocellular Carcinoma.Ann Surg Oncol. 2025 Oct;32(10):7679. doi: 10.1245/s10434-025-18151-6. Ann Surg Oncol. 2025. PMID: 40804571 No abstract available.
Conflict of interest statement
Disclosure: The authors have no relevant financial or non financial interests to disclose.
References
Publication types
Grants and funding
- SKLSIM-F-202443/the Youth Program of the Open Fund of the State Key Laboratory of Innovative Drug Research for Neurological and Oncological Disorders
- SC202401/the Sichuan Medical Association
- 81702093/National Natural Science Foundation of China
- 13ZB0243/the Youth Program of the Department of Education
LinkOut - more resources
Full Text Sources